Swang Chai Chuan Limited (02321.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 4Aug 7Aug 12Aug 17Aug 20Aug 25Aug 28Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

HKD 500.07M

MomentumView details →

1D Return

+0.00%

YTD Return

+21.95%

RSI (14)

44.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

HKD 500.07M

RSI (14)

44.7

MomentumView details →

1D Return

+0.00%

YTD Return

+21.95%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

1.72%

Div Rate

HKD 0.01

Div Growth 1Y

−36.30%

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Holista Colltech Ltd and Swang Chai Chuan Ltd formed a 50:50 joint venture, Ovicoll Pty Ltd, to develop and distribute collagen wound dressings, with Holista providing technical expertise and SCC providing RM5 million funding and distribution.14h ago

Similar companies

Dingdong (Cayman) LimitedDDL Clifford Modern Living Holdings Limited03686.HK Krispy Kreme, Inc.DNUT Village Super Market, Inc.VLGEA Natural Grocers by Vitamin Cottage, Inc.NGVC China Beidahuang Industry Group Holdings Limited00039.HK Find similar companies →

Latest newsMore news →

Holista Colltech Ltd and Swang Chai Chuan Ltd formed a 50:50 joint venture, Ovicoll Pty Ltd, to develop and distribute collagen wound dressings, with Holista providing technical expertise and SCC providing RM5 million funding and distribution.14h ago